Pfizer-BioNTech vaccine in patients undergoing cancer treatment
JAMA Oncology
2021-07-08
(Press-News.org) What The Study Did: The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccine appeared to be safe and achieve satisfactory serologic status in patients with cancer. While there was a lag in antibody production compared with the rate in the noncancer control group, seroconversion occurred in most patients after the second dose.
Authors: Irit Ben-Aharon, M.D., Ph.D., of the Rambam Health Care Campus in Haifa, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.2675)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2675?guestAccessKey=a006b52c-6abf-414d-b0b9-b57946450d20&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070821
ELSE PRESS RELEASES FROM THIS DATE:
2021-07-08
Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. "We've solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab", says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the results of her study are published in Nature Medicine.
While some cancer patients experience incredible results from immunotherapy, many others do not benefit from this treatment, which puts patients' ...
2021-07-08
What The Study Did: A decline in COVID-19 cases after the vaccination of health care workers in a region of California that experienced high rates of COVID-19 disease over the winter is reported in this single-center study.
Authors: Shruti K. Gohil, M.D., M.P.H., of the University of California, Irvine School of Medicine, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.15980)
Editor's Note: Please see the article for additional information, including other ...
2021-07-08
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer's. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
In addition, the experiments yielded seven drugs that may be useful for treating faulty proteins linked to Parkinson's ...
2021-07-08
HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The study, published today in Nature Medicine, also identified a potential new strategy to treat toxicity - while maintaining response - to combined immune checkpoint blockade through either IL-1R inhibition or manipulation of the gut microbiota.
Dual immune checkpoint therapy has contributed to progress in overall survival for many cancer types, including ...
2021-07-08
One of the things the human brain naturally excels at is recognizing all sorts of patterns, such as stripes on zebras, shells of turtles, and even the structure of crystals. Thanks to our progress in math and the natural sciences, we are not limited to just seeing the patterns; we can also understand how they readily originate out of pure randomness.
A notable example of different natural patterns with a single mathematical explanation are Turing patterns. Conceived in 1952 by the renowned mathematician Alan Turing, these patterns arise as the solutions to a set of differential equations that describe the diffusion and reaction of chemicals satisfying a few conditions. Going well beyond pure chemistry, Turing demonstrated ...
2021-07-08
Though writing by hand is increasingly being eclipsed by the ease of computers, a new study finds we shouldn't be so quick to throw away the pencils and paper: handwriting helps people learn certain skills surprisingly faster and significantly better than learning the same material through typing or watching videos.
"The question out there for parents and educators is why should our kids spend any time doing handwriting," says senior author Brenda Rapp, a Johns Hopkins University professor of cognitive science. "Obviously, you're going to be a better hand-writer if you practice it. But since people are handwriting less then maybe who cares? The real question is: Are there other benefits to handwriting that have to do with reading and spelling and ...
2021-07-08
Seismic waves passing through the ground near Longyearbyen in the Adventdalen valley, Svalbard, Norway have been slowing down steadily over the past three years, most likely due to permafrost warming in the Arctic valley.
The trend, reported in a new study published in Seismological Research Letters, demonstrates how seismic monitoring can be used to track permafrost stability under global climate change. The study is part of a focus section in an upcoming issue of the journal on Arctic and Antarctic seismology.
Julie Albaric of the University of Bourgogne Franche-Comté, while employed at NORSAR (Norway), and colleagues ...
2021-07-08
Coastal wetlands - such as salt marshes - provide even more flood protection than previously thought, reducing the risk to lives and homes in estuaries, a new study has revealed.
The researchers' simulations showed that wetlands that grow in estuaries, such as salt marshes, can reduce water levels by up to 2 metres and provide protection far inland up estuary channels.
This subsequently saved up to $38 (£27) million in avoided flood damage costs per estuary during a large storm thanks to the wetlands' role in preventing storm floods.
The research is timely as wetlands are facing growing threats from continued urban development. 22 of the largest 32 cities in the world - including London, New York and Tokyo - are built on low-lying land around estuaries, ...
2021-07-08
Populist anti-foreign aid rhetoric works - but only fans of populist politicians are convinced by hostile messages about charity abroad, a new study shows. Those who distrust populist politicians are significantly less susceptible to these messages.
The research shows international aid institutions and non-populist politicians should not be unduly worried about the impact of populism on global development cooperation.
Those wanting to convince the public about the importance of foreign aid should focus on communicating their message transparently and clearly, and using local partnerships.
The research, by A. Burcu Bayram from the University of Arkansas and Catarina Thomson from ...
2021-07-08
Concerns have been raised about the AstraZeneca and Johnson & Johnson vaccines regarding very rare but potentially fatal side effects related to low blood platelet counts and blood clots. Recently, reports also emerged that the Pfizer-BioNTech vaccine may cause a rare yet serious side effect: heart inflammation. Concerns about side effects may trigger vaccine hesitancy, which the WHO considers one of 'Ten threats to global health'. Securing sufficient acceptance of vaccines is a key challenge in defeating the coronavirus pandemic, both now and in the future.
How ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pfizer-BioNTech vaccine in patients undergoing cancer treatment
JAMA Oncology
